S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CYTO Altamira Therapeutics Ltd

0.30

0.00 (0.00%)

22 Jan 2025 - Closed

Delayed by 15 minutes

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

null

Altamira Therapeutics (NASDAQ:CYTO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Altamira Therapeutics Charts.

Altamira Therapeutics (NASDAQ:CYTO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Altamira Therapeutics Charts.

Altamira Therapeutics Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 21 December 2024 (1 month ago) • Edgar (US Regulatory)

Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets
Saturday 21 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 5 October 2024 (4 months ago) • Edgar (US Regulatory)

Altamira Therapeutics Provides Update on Nasdaq Listing
Saturday 5 October 2024 (4 months ago) • GlobeNewswire Inc.

Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
Friday 27 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 24 September 2024 (4 months ago) • Edgar (US Regulatory)

Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
Tuesday 24 September 2024 (4 months ago) • GlobeNewswire Inc.

Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
Friday 20 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 20 September 2024 (4 months ago) • Edgar (US Regulatory)

Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
Friday 20 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]
Thursday 19 September 2024 (4 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 18 September 2024 (4 months ago) • Edgar (US Regulatory)

More Altamira Therapeutics Ltd News Articles

Gold vs US Dollar

Westpac Banking

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions